Connecting with the Investment Community Edgewise Therapeutics, a clinical-stage biopharmaceutical company focused on developing therapies for rare muscle disorders, has officially announced its upcoming participation in key investor conferences. These events serve as a vital platform for the company to provide updates on its strategic initiatives and ongoing research programs. Marking the Calendar Management from…